Back to results
CompletedPhase 1

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

NCT03000257

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Moores Cancer Center at UC San Diego /ID# 157374

La Jolla, California, United States

+25 additional locations

View on ClinicalTrials.gov